Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver

Cell Metab. 2008 Mar;7(3):227-35. doi: 10.1016/j.cmet.2007.12.007.

Abstract

Alcohol-induced fatty liver, a major cause of morbidity, has been attributed to enhanced hepatic lipogenesis and decreased fat clearance of unknown mechanism. Here we report that the steatosis induced in mice by a low-fat, liquid ethanol diet is attenuated by concurrent blockade of cannabinoid CB1 receptors. Global or hepatocyte-specific CB1 knockout mice are resistant to ethanol-induced steatosis and increases in lipogenic gene expression and have increased carnitine palmitoyltransferase 1 activity, which, unlike in controls, is not reduced by ethanol treatment. Ethanol feeding increases the hepatic expression of CB1 receptors and upregulates the endocannabinoid 2-arachidonoylglycerol (2-AG) and its biosynthetic enzyme diacylglycerol lipase beta selectively in hepatic stellate cells. In control but not CB1 receptor-deficient hepatocytes, coculture with stellate cells from ethanol-fed mice results in upregulation of CB1 receptors and lipogenic gene expression. We conclude that paracrine activation of hepatic CB1 receptors by stellate cell-derived 2-AG mediates ethanol-induced steatosis through increasing lipogenesis and decreasing fatty acid oxidation.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Animals
  • Arachidonic Acids / metabolism
  • Cannabinoid Receptor Modulators / metabolism*
  • Carnitine O-Palmitoyltransferase / metabolism
  • Cells, Cultured
  • Coculture Techniques
  • Diet, Fat-Restricted
  • Disease Models, Animal
  • Endocannabinoids*
  • Ethanol
  • Fatty Acid Synthases / metabolism
  • Fatty Acids / metabolism
  • Fatty Liver, Alcoholic / etiology
  • Fatty Liver, Alcoholic / genetics
  • Fatty Liver, Alcoholic / metabolism*
  • Fatty Liver, Alcoholic / pathology
  • Fatty Liver, Alcoholic / prevention & control
  • Glycerides / metabolism
  • Hepatocytes / metabolism
  • Lipogenesis* / drug effects
  • Lipogenesis* / genetics
  • Lipoprotein Lipase / metabolism
  • Liver / drug effects
  • Liver / enzymology
  • Liver / metabolism*
  • Liver / pathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Oxidation-Reduction
  • Paracrine Communication* / drug effects
  • Paracrine Communication* / genetics
  • Piperidines / pharmacology
  • Pyrazoles / pharmacology
  • Receptor, Cannabinoid, CB1 / antagonists & inhibitors
  • Receptor, Cannabinoid, CB1 / genetics
  • Receptor, Cannabinoid, CB1 / metabolism*
  • Rimonabant
  • Sterol Regulatory Element Binding Protein 1 / metabolism
  • Up-Regulation

Substances

  • Arachidonic Acids
  • Cannabinoid Receptor Modulators
  • Endocannabinoids
  • Fatty Acids
  • Glycerides
  • Piperidines
  • Pyrazoles
  • Receptor, Cannabinoid, CB1
  • Srebf1 protein, mouse
  • Sterol Regulatory Element Binding Protein 1
  • Ethanol
  • glyceryl 2-arachidonate
  • Carnitine O-Palmitoyltransferase
  • Fatty Acid Synthases
  • Lipoprotein Lipase
  • Rimonabant